Juerg Witmer - Syngenta Non - Executive Vice Chairman of the Board
Chairman
Mr. Juerg Witmer was NonExecutive Director, Lead Independent Director at Syngenta Ltd since 2018. He was NonExecutive Independent Director at Syngenta Ltd from 2017. He previously was NonExecutive Vice Chairman of the Board of the Company from 2009. He is Member of the Compensation Committee and Nomination Governance Committee. He joined HoffmannLa Roche in Basel in 1978 and subsequently held a number of positions including Legal Counsel, Assistant to the Chief Executive Officer, General Manager and China Project Manager of Roche Far East based in Hong Kong, Head of Corporationrationrate Communications and Public Affairs at Roche headquarters in Basel, Switzerland, and General Manager of Roche Austria. From 1999 to 2005, he acted as Chief Executive Officer of the Givaudan Group in VernierGeneva. From 2008 to 2012, he was also Chairman of Clariant AG, Basel. Apart from his functions in Syngenta, he is Chairman of Givaudan Group and NonExecutive Director of A. Menarini IFR Florence. He has a doctorate in Law from the University of Zurich, as well as a degree in International Studies from the Graduate Institute of the University of Geneva. since 2018.
| Age | 69 |
| Tenure | 6 years |
| Professional Marks | Ph.D |
| Phone | 41 61 323 1111 |
| Web | http://www.syngenta.com |
Syngenta Management Efficiency
The company has return on total asset (ROA) of 5.85 % which means that it generated a profit of $5.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.45 %, meaning that it generated $12.45 on every $100 dollars invested by stockholders. Syngenta's management efficiency ratios could be used to measure how well Syngenta manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 5.63 B in total debt with debt to equity ratio (D/E) of 63.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Syngenta AG has a current ratio of 1.6, which is within standard range for the sector. Debt can assist Syngenta until it has trouble settling it off, either with new capital or with free cash flow. So, Syngenta's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Syngenta AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Syngenta to invest in growth at high rates of return. When we think about Syngenta's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Gordon Nixon | BCE Inc | 64 | |
| Martine Turcotte | BCE Inc | 57 | |
| Alexander Wynaendts | Aegon NV ADR | 59 | |
| Thomas ONeill | BCE Inc | 70 | |
| Irving Bailey | Aegon NV ADR | 74 | |
| Robert Routs | Aegon NV ADR | 70 | |
| William Connelly | Aegon NV ADR | 63 | |
| Elaine Rosen | Assurant | 68 | |
| Neil Sorahan | Ryanair Holdings PLC | 53 | |
| Corien WortmannKool | Aegon NV ADR | 62 | |
| Karine Moses | BCE Inc | N/A | |
| David Bonderman | Ryanair Holdings PLC | 75 | |
| Eduardo Eurnekian | Corporacion America Airports | 84 | |
| Maximo Bomchil | Corporacion America Airports | 69 | |
| Wade Oosterman | BCE Inc | 63 | |
Management Performance
| Return On Equity | 12.45 | |||
| Return On Asset | 5.85 |
Syngenta AG Leadership Team
Elected by the shareholders, the Syngenta's board of directors comprises two types of representatives: Syngenta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Syngenta. The board's role is to monitor Syngenta's management team and ensure that shareholders' interests are well served. Syngenta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Syngenta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew McConville, Investor Relations Contact Officer | ||
| Jeff Rowe, President Global Seeds and North America, Member of the Executive Committee | ||
| Christoph Maeder, Member of the Executive Committee, Head of Legal & Taxes, Secretary | ||
| John Ramsay, Interim CEO and CFO | ||
| Jonathan Seabrook, Head of Corporate Affairs | ||
| Sophie KornowskiBonnet, Non-Executive Independent Director | ||
| Mark Titterington, Head Corporate Affairs | ||
| Davor Pisk, COO | ||
| Gaoning Ning, Non-Executive Chairman of the Board | ||
| Jianxin Ren, Non-Executive Chairman of the Board | ||
| Gunnar Brock, Non-Executive Independent Director | ||
| Eleni GabreMadhin, Non-Executive Director | ||
| Jonathan Parr, COO | ||
| Vinita Bali, Non-Executive Independent Director | ||
| Mark Peacock, Head of Global Operations | ||
| Stefan Borgas, Non-Executive Director | ||
| John Atkin, COO | ||
| Hongbo Chen, Non-Executive Director | ||
| David Lawrence, Non-Executive Director | ||
| Michel Demare, Chairman of the Board | ||
| Olivier ClermontTonnerre, Non-Executive Director | ||
| Carl Casale, Non-Executive Independent Director | ||
| Stephen Landsman, Group General Counsel, Member of the Executive Committee | ||
| Caroline Luscombe, Head of HR | ||
| Dieter Gericke, Non-Executive Director | ||
| Alexandra Brand, Chief Sustainability Officer | ||
| Patricia Malarkey, Head Research & Development | ||
| Jacques Vincent, Non-Executive Director | ||
| Juerg Witmer, Non - Executive Vice Chairman of the Board | ||
| Eveline Saupper, Non-Executive Director | ||
| Alexander Tokarz, Head Business Development | ||
| Jennifer Gough, IR Contact Officer | ||
| Mark Patrick, CFO, Member of the Executive Committee | ||
| Erik Fyrwald, CEO | ||
| Laure Roberts, Head Human Resources | ||
| Paul Fribourg, Non-Executive Director |
Syngenta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Syngenta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 12.45 | |||
| Return On Asset | 5.85 | |||
| Profit Margin | 8.26 % | |||
| Operating Margin | 16.20 % | |||
| Current Valuation | 45 B | |||
| Shares Outstanding | 92.33 M | |||
| Price To Earning | 40.86 X | |||
| Price To Book | 4.83 X | |||
| Price To Sales | 3.46 X | |||
| Revenue | 12.62 B |
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Syngenta Pink Sheet
If you are still planning to invest in Syngenta AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syngenta's history and understand the potential risks before investing.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |